positronemissiontomography(pet)scansinovariancancer.pptVIP

Positron Emission Tomography PET Scans in Ovarian Cancer Effectiveness of PET Scans and Recommendations for CMS August 20, 2008 Contents Ovarian Cancer Background Ovarian Cancer National Alliance OCNA Coverage with Evidence Decision PET Scans in Ovarian Cancer: Initial Diagnosis PET Scans in Ovarian Cancer: Recurrence PET Scans in Ovarian Cancer: Monitoring Treatment Recommendations Ovarian Cancer Background This year, 21,650 American women will be diagnosed with ovarian cancer, and 15,520 will die from the disease American Cancer Society, 2008 Deadliest gynecologic cancer and the 5th leading cause of cancer death among women Less than half of the women diagnosed will die within five years Ovarian Cancer Background con’t Initial Detection 20% women diagnosed in early most treatable cancer stages No reliable early detection test Combination of pelvic/rectal exam, transvaginal ultrasound and CA-125 serum blood test used for detection Recurrence 70% ovarian cancer patients CA-125 may be early route to detect recurrence CA-125 inaccurate picture of extent of disease or falsely elevated Radiologic devices i.e. PET scans Cancer extent and location Ovarian Cancer National Alliance  OCNA Coverage with Evidence Decision PET Scans in Ovarian Cancer: Initial Diagnosis PET Scans in Ovarian Cancer: Recurrence PET Scans in Ovarian Cancer: Monitoring Treatment Recommendations * Ovarian Cancer National Alliance Ovarian Cancer National Alliance Ovarian Cancer National Alliance Ovarian Cancer National Alliance Ovarian Cancer National Alliance National umbrella organization with state and local groups Represents grassroots activists, women’s health advocates and health care professionals Patient advocacy group dedicated to conquering ovarian cancer Ovarian Cancer National Alliance Centers for Medicare and Medicaid Services’ CMS’ Coverage with Evidence Decision CED PET or PET/CT scans Covers Medicare patients Part of a clinical